Health Care Stocks Move Up As Deals And Drug Trials Land

Health care stocks are rising due to Cencora's $7.4 billion acquisition of OneOncology, positive results from Immunome's drug trial for desmoid tumors (stock soared over 20%), and Eli Lilly's strong growth forecast for its weight-loss medicines. The NYSE Health Care Index advanced nearly 1%, with investors favoring companies showing clinical wins and strategic deal-making.